![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
LONDON BROKER RATINGS: Morgan Stanley cuts WPP to 'underweight'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read moreWed, 23rd Sep 2009 13:10
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more(Alliance News) - European equities made a confident start to the new trading week on Monday, for now setting aside the inflation and economic growth worries that have stifled markets in recent weeks and months.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.
Read more(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.
Read moreTRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist
Read more(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.
Read moreEXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group
Read moreEXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET
Read moreEARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
Read more(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.
Read moreIN BRIEF: Futura Medical teams with Labatec to commercialise MED3000
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Futura progressing US regulatory submission for MED3000
Read moreTRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners
Read more